1. Hong JS, Kang HC. Oral antihyperglycemic medication adherence and its associated factors among ambulatory care with adult type 2 diabetes patients in Korea. Korean J Health Policy Adm. 2010; 20(2):128–143. DOI:
10.4332/KJHPA.2010.20.2.128.
2. Korean Diabetes Association. Korean diabetes fact sheet 2013. Seoul: Author;2013.
3. Brod M, Kongsø JH, Lessard S, Christensen TL. Psychological insulin resistance: Patient beliefs and implications for diabetes management. Qual Life Res. 2009; 18(1):23–32. DOI:
10.1007/s11136-008-9419-1.
4. Peyrot M, Rubin RR, Lauritzen T, Skovlund SE, Snoek FJ, Matthews DR, et al. Resistance to insulin therapy among patients and providers: Results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study. Diabetes Care. 2005; 28(11):2673–2679. DOI:
10.2337/diacare.28.11.2673.
5. Fu SN, Chin WY, Wong CK, Yeung VT, Yiu MP, Tsui HY, et al. Development and validation of the Chinese Attitudes to Starting Insulin Questionnaire (Ch-ASIQ) for primary care patients with type 2 diabetes. PloS One. 2013; 8(11):e78933. DOI:
10.1371/journal.pone.0078933.
6. Hong SH, Kim MJ, Noh SG, Suh DW, Youn SJ, Lee KW, et al. A study on resistance in type 2 diabetic patient against commencement of insulin treatment. J Korean Diabetes. 2008; 32(3):269–279. DOI:
10.4093/kdj.2008.32.3.269.
7. Petrak F, Stridde E, Leverkus F, Crispin AA, Forst T, Pfützner A. Development and validation of a new measure to evaluate psychological resistance to insulin treatment. Diabetes Care. 2007; 30(9):2199–2204. DOI:
10.2337/dc06-2042.
8. Polonsky WH, Fisher L, Guzman S, Villa-Caballero L, Edelman SV. Psychological insulin resistance in patients with type 2 diabetes: The scope of the problem. Diabetes Care. 2005; 28(10):2543–2555. DOI:
10.1016/s1751-9918(10)60004-6.
9. Peyrot M, Rubin RR, Khunti K. Addressing barriers to initiation of insulin in patients with type 2 diabetes. Prim Care Diabetes. 2010; 4:Suppl 1. S11–S18.
10. Lee EW. Self-injection related anxiety, fear and self-care compliance in insulin-treated diabetes patients [master's thesis]. Seoul: Ewha Womans University;2002. 1–69.
11. Larkin ME, Capasso VA, Chen CL, Mahoney EK, Hazard B, Cagliero E, et al. Measuring psychological insulin resistance: Barriers to insulin use. Diabetes Educ. 2008; 34(3):511–517. DOI:
10.1177/0145721708317869.
12. Nam S, Song HJ, Park SY, Song Y. Challenges of diabetes management in immigrant Korean Americans. Diabetes Educ. 2013; 39(2):213–221. DOI:
10.1177/0145721713475846.
13. Reach G, Le Pautremat V, Gupta S. Determinants and consequences of insulin initiation for type 2 diabetes in France: Analysis of the National Health and Wellness Survey. Patient Prefer Adherence. 2013; 7:1007–1023. DOI:
10.2147/ppa.s51299.
14. Schwartz-Barcott D, Kim HS. An expansion and elaboration of the hybrid model of concept development. In : Rodgers BL, Knafl KA, editors. Concept development in Nursing: Foundations, techniques, and applications. 2nd ed. Philadelphia, PA: W.B. Sanders;2000. p. 161–192.
15. Hsieh HF, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005; 15(9):1277–1288. DOI:
10.1177/1049732305276687.
16. Strauss AL, Corbin JM. Basics of qualitative research: Techniques and procedures for developing grounded theory. Thousand Oaks, CA: Sage Publications;1998. p. 55–101.
18. Kang MR. Relationships among psychological insulin resistance diabetes knowledge and self-efficacy in patients with type 2 diabetes [master's thesis]. Seoul: Yonsei University;2014. 1–71.
19. Gherman A, Veresiu IA, Sassu RA, Schnur JB, Scheckner BL, Montgomery GH. Psychological insulin resistance: A critical review of the literature. Pract Diabetes Int. 2011; 28(3):125d–128d. DOI:
10.1002/pdi.1574.
20. Farsaei S, Radfar M, Heydari Z, Abbasi F, Qorbani M. Insulin adherence in patients with diabetes: Risk factors for injection omission. Prim Care Diabetes. 2014; 8(4):338–345. DOI:
10.1016/j.pcd.2014.03.001.
21. Machinani S, Bazargan-Hejazi S, Hsia SH. Psychological insulin resistance among low-income, U.S. racial minority patients with type 2 diabetes. Prim Care Diabetes. 2013; 7(1):51–55. DOI:
10.1016/j.pcd.2012.11.003.
22. Brunton S. Insulin delivery systems: reducing barriers to insulin therapy and advancing diabetes mellitus treatment. Am J Med. 2008; 121:6 Suppl. S35–S41. DOI:
10.1016/j.amjmed.2008.03.025.
23. Makine C, Karşidağ C, Kadioğlu P, Ilkova H, Karşidağ K, Skovlund SE, et al. Symptoms of depression and diabetes-specific emotional distress are associated with a negative appraisal of insulin therapy in insulin-naive patients with Type 2 diabetes mellitus. A study from the European Depression in Diabetes [EDID] Research Consortium. Diabet Med. 2009; 26(1):28–33. DOI:
10.1111/j.1464-5491.2008.02606.x.
24. Abu Hassan H, Tohid H, Mohd Amin R, Long Bidin MB, Muthupalaniappen L, Omar K. Factors influencing insulin acceptance among type 2 diabetes mellitus patients in a primary care clinic: A qualitative exploration. BMC Fam Pract. 2013; 14:164. DOI:
10.1186/1471-2296-14-164.
25. Polonsky WH, Anderson BJ, Lohrer PA, Welch G, Jacobson AM, Aponte JE, et al. Assessment of diabetes-related distress. Diabetes Care. 1995; 18(6):754–760. DOI:
10.2337/diacare.18.6.754.
26. Snoek FJ, Skovlund SE, Pouwer F. Development and validation of the insulin treatment appraisal scale (ITAS) in patients with type 2 diabetes. Health Qual Life Outcomes. 2007; 5:69. DOI:
10.1186/1477-7525-5-69.
27. Karter AJ, Subramanian U, Saha C, Crosson JC, Parker MM, Swain BE, et al. Barriers to insulin initiation: The translating research into action for diabetes insulin starts project. Diabetes Care. 2010; 33(4):733–735. DOI:
10.2337/dc09-1184.